Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant of COVID-19: UK govt study
The Oxford/AstraZeneca two-dose vaccine is also being produced by the Serum Institute of India as Covishield and being administered among the adult... Read More
Serum Institute of India to make £240 mn investments in UK, create 6,500 jobs
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines.It was also revealed that the Serum Institute of... Read More
Adar Poonawalla Says Will Return From UK “In Few Days”, Vaccine On Track
Serum Institute of India’s Covishield – developed in partnership with the Oxford University and British-Swedish pharma giant AstraZeneca – is one of... Read More
